Clinical Trial Update: Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating sofosbuvir with ribavirin or simeprevir in Egyptian patients with chronic hepatitis C virus infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Simeprevir (simeprevir)
• sofosbuvir with ribavirin (sofosbuvir; ribavirin)

Snippet

Sponsor: Beni-Suef University | Conditions: Chronic Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED